World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 6193209

Number of visits today: 2917

Number of downloads: 4380118

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 4 (761)

Contents Volume 5 Issue 4 April 15, 2013

Review

Current oncologic applications of radiofrequency ablation therapies

Dhruvil R Shah, Sari Green, Angelina Elliot, John P McGahan, Vijay P Khatri

World J Gastrointest Oncol 5(4):71-80. Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.71

Abstract (1432) | Core Tip (1328) | Full Article (HTML) (5296) | Tables (1-5) (638) | Full Article (PDF)-726K (607) | Received: 02/01/2013 | Revised: 03/10/2013 | Accepted: 03/15/2013 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (115) | Timeline of Article Publication (0) | Cite | (0) | (0) | (0) | (6541) | (81) | Open

Brief Article

Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy

Kosin Wirasorn, Thundon Ngamprasertchai, Jarin Chindaprasirt, Aumkhae Sookprasert, Narong Khantikaew, Ake Pakkhem, Piti Ungarereevittaya

World J Gastrointest Oncol 5(4):81-87. Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81

Abstract (1365) | Core Tip (1392) | Full Article (HTML) (4539) | Figures (1-2) (531) | Tables (1-4) (519) | Full Article (PDF)-944K (547) | Received: 11/17/2012 | Revised: 03/05/2013 | Accepted: 03/15/2013 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (375) | Timeline of Article Publication (0) | Cite | (0) | (0) | (0) | (6136) | (8) | Open

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.